Involvement of PARK2-mediated mitophagy in idiopathic pulmonary fibrosis pathogenesis
K Kobayashi, J Araya, S Minagawa… - The Journal of …, 2016 - Am Assoc Immnol
... 658551), BGJ398, a fibroblast growth factor receptor inhibitor (Selleck Chemicals, no. S2183),
axitinib, a vascular endothelial growth factor receptor inhibitor (Selleck Chemicals, no. S1005),
pepstatin A (Peptide Institute, no. 4397), E64d (Peptide Institute, no. ...
Peptide synthesis, peptide modification and peptide library synthesis, please contact:
Eva He
eva@pepmic.com
Pepmic Co., Ltd
www.pepmic.com
axitinib, a vascular endothelial growth factor receptor inhibitor (Selleck Chemicals, no. S1005),
pepstatin A (Peptide Institute, no. 4397), E64d (Peptide Institute, no. ...
Eva He
eva@pepmic.com
Pepmic Co., Ltd
www.pepmic.com
没有评论:
发表评论